Skip to main content
Erschienen in:

01.05.2020 | Original Article

The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study

verfasst von: Ipek Inci, Ozge Yılmaz Kusbeci, Neslihan Eskut

Erschienen in: Neurological Sciences | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

To evaluate the neutrophil-to-lymphocyte ratio (NLR) levels in the peripheral blood of patients with progressive supranuclear palsy (PSP), and to compare them with levels in patients with idiopathic Parkinson’s disease (PD) and healthy controls.

Methods

Twenty-one patients with probable PSP, 42 with PD, and 40 age-matched healthy volunteers were enrolled in the study. Demographic data and duration of disease, comorbid systemic disease, and smoking status were recorded. NLR was calculated by dividing neutrophil count by the lymphocyte count.

Results

The mean age of patients with PSP was 68.28 ± 8.7 years and the mean duration of disease was 5.09 ± 2.52 years. The mean age in PD group was 66.59 ± 9.54 years and 65.05 ± 6.52 years in the healthy volunteer group. There were no significant differences in ages between the PSP group and the other two groups (p = 0.498; p = 0.107, respectively). The PSP group consisted of four female and 17 male patients. The PD group comprised 19 female and 23 male patients. There were 18 female and 2 male in the healthy volunteer group. The mean NLR value in the PSP group was significantly higher than in the PD group and healthy controls (p = 0.023; p = 0.001, respectively). The mean NLR value in the PD group was not significantly different from the healthy controls (p = 0.593).

Conclusion

NLR values were found higher in the PSP group. The result of this study revealed the existence of peripheral inflammation in patients with PSP.
Literatur
1.
Zurück zum Zitat Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and serebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10(4):333–359CrossRef Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and serebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10(4):333–359CrossRef
2.
Zurück zum Zitat Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552–563CrossRef Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552–563CrossRef
3.
Zurück zum Zitat Kovacs G (2015) Neuropathology of tauopaties: principles and practice. Neuropathol Appl Neurobiol 41(1):3–23CrossRef Kovacs G (2015) Neuropathology of tauopaties: principles and practice. Neuropathol Appl Neurobiol 41(1):3–23CrossRef
4.
Zurück zum Zitat Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 60(6):647–657CrossRef Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 60(6):647–657CrossRef
5.
Zurück zum Zitat Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. Jci1 27(10):3577–3587CrossRef Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. Jci1 27(10):3577–3587CrossRef
6.
Zurück zum Zitat Khandelwal PJ, Herman AM, Moussa CE-H (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238(1–2):1–11CrossRef Khandelwal PJ, Herman AM, Moussa CE-H (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238(1–2):1–11CrossRef
7.
Zurück zum Zitat Zahorec R (2001) Ratio of neutrophil to lymphocyte count: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14PubMed Zahorec R (2001) Ratio of neutrophil to lymphocyte count: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14PubMed
8.
Zurück zum Zitat Kuyumcu ME, Yeşil Y, Ozturk ZA, Kızılarslanoglu C, Atgul S, Halil M et al (2012) The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord 34(2):69–74CrossRef Kuyumcu ME, Yeşil Y, Ozturk ZA, Kızılarslanoglu C, Atgul S, Halil M et al (2012) The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord 34(2):69–74CrossRef
9.
Zurück zum Zitat Rembach A, Watt AD, Wilson WL, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD, AIBL Research Group (2014) An increased neutrophil-lymphocyte ratio in Alzheimer’s disease is function of age and is weakly correlated with neocortical amyloid accumulation. J Neuroimmunol 273(1–2):65–71CrossRef Rembach A, Watt AD, Wilson WL, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD, AIBL Research Group (2014) An increased neutrophil-lymphocyte ratio in Alzheimer’s disease is function of age and is weakly correlated with neocortical amyloid accumulation. J Neuroimmunol 273(1–2):65–71CrossRef
10.
Zurück zum Zitat Akıl E, Bulut A, Kaplan I, Ozdemir HH, Arslan D, Aluçlu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. NeurolSci 36(3):423–428 Akıl E, Bulut A, Kaplan I, Ozdemir HH, Arslan D, Aluçlu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. NeurolSci 36(3):423–428
11.
Zurück zum Zitat Kücük E, Kocayiğit İ, Günel C, Düzenli H (2016) Neutrophil-to-lymphocyte ratio in occlusive vascular disease: the literature review of the past 10 years. World J Emerg Med 7(3):165–172CrossRef Kücük E, Kocayiğit İ, Günel C, Düzenli H (2016) Neutrophil-to-lymphocyte ratio in occlusive vascular disease: the literature review of the past 10 years. World J Emerg Med 7(3):165–172CrossRef
12.
Zurück zum Zitat Ozbay I, Kahraman C, Balıkcı HH, Kucur C, Karaman NK, Ozkaya DP (2014) Neutrophil-to-lymphocyte ratio inpatients with peripheral vertigo: a prospective controlled clinical study. Am J Otolaryngol 35(6):699–702CrossRef Ozbay I, Kahraman C, Balıkcı HH, Kucur C, Karaman NK, Ozkaya DP (2014) Neutrophil-to-lymphocyte ratio inpatients with peripheral vertigo: a prospective controlled clinical study. Am J Otolaryngol 35(6):699–702CrossRef
13.
Zurück zum Zitat Corriere T, Marca D, Cataudella E, Pulvirenti A, Stancanelli SA, Malatino L (2018) Neutrophil-to-lymphocyte ratio is a strong predictor of atherosclerotic carotid plaque in older adults. Nutr Metab Cardiovasc Dis 28(1):23–27CrossRef Corriere T, Marca D, Cataudella E, Pulvirenti A, Stancanelli SA, Malatino L (2018) Neutrophil-to-lymphocyte ratio is a strong predictor of atherosclerotic carotid plaque in older adults. Nutr Metab Cardiovasc Dis 28(1):23–27CrossRef
14.
Zurück zum Zitat Woong Nam K, Min Kwon H, YeongJeong H, Ho Park J, Kim SH, Min Jeong S (2018) High neutrophil-to-lymphocyte ratio predict intracranial atherosclerosis in healthy population. Atherosclerosis 269:117–121CrossRef Woong Nam K, Min Kwon H, YeongJeong H, Ho Park J, Kim SH, Min Jeong S (2018) High neutrophil-to-lymphocyte ratio predict intracranial atherosclerosis in healthy population. Atherosclerosis 269:117–121CrossRef
15.
Zurück zum Zitat Zeng Z, Wang C, Wang B, Wang N, Yang Y, Guo S, Du Y (2019) Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression autoimmune encephalitis. Neurosci Lett 694:129–135CrossRef Zeng Z, Wang C, Wang B, Wang N, Yang Y, Guo S, Du Y (2019) Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression autoimmune encephalitis. Neurosci Lett 694:129–135CrossRef
16.
Zurück zum Zitat Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang A et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorders society criteria. Mov Disord 32(6):853–864CrossRef Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang A et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorders society criteria. Mov Disord 32(6):853–864CrossRef
17.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef
18.
Zurück zum Zitat Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson S et al (2011) Cytokine expression and microbial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17(9):683–688CrossRef Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson S et al (2011) Cytokine expression and microbial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17(9):683–688CrossRef
19.
Zurück zum Zitat Hasson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U et al (2017) Blood based Nfl: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930–937CrossRef Hasson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U et al (2017) Blood based Nfl: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930–937CrossRef
20.
Zurück zum Zitat Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinson Relat Disorders 56:98–101CrossRef Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinson Relat Disorders 56:98–101CrossRef
21.
Zurück zum Zitat Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian symptoms. J Neurol Neurosurg Psychiatry 86(11):1240–1247CrossRef Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian symptoms. J Neurol Neurosurg Psychiatry 86(11):1240–1247CrossRef
22.
Zurück zum Zitat Olsson B, Constantinescu R, Holberg B, Andreassen N, Blennow K, Zetterberg H (2013) The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord 28(13):1882–1885CrossRef Olsson B, Constantinescu R, Holberg B, Andreassen N, Blennow K, Zetterberg H (2013) The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord 28(13):1882–1885CrossRef
24.
Zurück zum Zitat Azab B, Camacho-Rivera M, Taioli E (2014) Average values and racial differences of neutrophil-lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 9(11):e112361CrossRef Azab B, Camacho-Rivera M, Taioli E (2014) Average values and racial differences of neutrophil-lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 9(11):e112361CrossRef
25.
Zurück zum Zitat Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L (2014) Neutrophil to lymphocyte ratio in relation to risk of all cause of mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis observational studies. Atherosclerosis 234(1):206–213CrossRef Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L (2014) Neutrophil to lymphocyte ratio in relation to risk of all cause of mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis observational studies. Atherosclerosis 234(1):206–213CrossRef
26.
Zurück zum Zitat Eryıgıt U, AltunayogluCakmak V, Sahin A, Tatlı O, Paslı S, Gazioglu G et al (2017) The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorage and migraine. Am J Emerg Med 35(9):1276–1280CrossRef Eryıgıt U, AltunayogluCakmak V, Sahin A, Tatlı O, Paslı S, Gazioglu G et al (2017) The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorage and migraine. Am J Emerg Med 35(9):1276–1280CrossRef
27.
Zurück zum Zitat Ucar Ataç C, Cokal BG, Artık UHA, Inan LE, Yoldas TK (2017) Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38(2):287–293CrossRef Ucar Ataç C, Cokal BG, Artık UHA, Inan LE, Yoldas TK (2017) Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38(2):287–293CrossRef
Metadaten
Titel
The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study
verfasst von
Ipek Inci
Ozge Yılmaz Kusbeci
Neslihan Eskut
Publikationsdatum
01.05.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 5/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04208-4

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Demenz-Leitlinie aktualisiert

  • 13.03.2025
  • Demenz
  • Nachrichten

Empfohlen wird jetzt auch eine Musiktherapie sowie bei unklarem diagnostischem Befund ein Tau-PET, und Depressive mit leichten kognitiven Störungen sollten eine Verhaltenstherapie erhalten – das sind einige wichtige Änderungen der aktuellen S3-Leitlinie Demenzen.

Frauen akkumulieren Tau-Protein schneller als Männer

Frauen mit einer hohen Beta-Amyloid-Last im Gehirn aggregieren mehr Tau-Protein als Männer mit vergleichbaren Amyloidwerten. Ähnliches gilt für Frauen mit einem ApoE4-Allel. Dafür sprechen die Daten einer Metaanalyse von Menschen im präklinischen Alzheimerstadium.

Frauen mit Apoplex in Deutschland nicht benachteiligt – oder doch?

Eine Analyse von Daten des statistischen Bundesamtes spricht dafür, dass Frauen in der Schlaganfallbehandlung nicht benachteiligt sind. Im Detail bleiben aber Fragen offen.

MS-Medikamente absetzen: ab 60 Jahren eine Option

Wann können ältere MS-Kranke ihre krankheitsmodifizierende Therapie gefahrlos absetzen? Bisher lieferten kontrollierte Studien hier keine eindeutigen Antworten. Eine neue Auswertung der Studie DISCOMS deutet auf einen grenzwertigen Nutzen ab 60 Jahren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.